Company Profile
Updated: 13-NOV-09AstraZeneca S.A.
International subsidiary
4 Theotokopoulou and Astronafton Str, Maroussi, Athens, GR-151 25, Greece
()30 210 687 1500, 30 210 648 7968 fax, http://www.astrazeneca.com
Primary SIC: Drugs, Proprietaries And Sundries, Primary NAICS: Drugs and Druggists' Sundries Merchant Wholesalers
Description: Wholesale: Import, distribution and marketing of pharmaceuticals
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
AstraZeneca and the Philadelphia Department of Public Health Provide Free Medicines to Pennsylvania's Uninsured.
Pediatrics Week; 12/12/2009; 1285 words; AstraZeneca (NYSE: AZN) and...Care Center #6 that AstraZeneca will provide free medicines to the city's Health Centers to help...four. "The City's budget crisis has forced...We are grateful to AstraZeneca for their prescription...
Research and Markets Adds Report: Procter & Gamble: Pipeline, Products, Performance and Potential
Manufacturing Close-Up; 12/11/2009; 687 words; ...full review of the company's activities together with five...comprehensive review of the company's product portfolio and research...Alexion Pharmaceuticals - ARYx - AstraZeneca - Chemokine Therapeutics - Cincinnati Children's Hospital Medical Centre - Curis...
Crohn's Disease - A Complete Drug Pipeline Analysis and Market Forecasts Through to 2015.
M2 Presswire; 12/9/2009; 1206 words; ...biologics, their launch has increased the competition in the Crohn's disease market. Johnson & Johnson's Remicade is the market leader and is followed by Astrazeneca/Promethus's Entocort EC, Biogen Idec's Tysabri and Abbott's Humira respectively...
The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis.
M2 Presswire; 12/9/2009; 1664 words; ...on the respiratory market's potential, actual sales, actual...elucidates the respiratory disease's competitive landscape including...9 billion to the market. Astrazeneca contributed approximately...this report are Novartis AG, AstraZeneca and Merck & Co - Key M&A activities...
The Future of Autoimmune Diseases Therapeutics A[cent sign]a'[not sign]a[euro]oe Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deal Analysis.
M2 Presswire; 12/9/2009; 1754 words; ...multiple sclerosis, systemic lupus, erythematosus, crohn's disease and ulcerative colitis - Analysis of the autoimmune...Hoffmann-La Roche, Novartis AG, Sanofi-aventis, Amgen Inc, AstraZeneca, Merck & Co, Pfizer Inc, Celgene Corporation, Bristol...
Recent News Articles
- AstraZeneca Among Working Mother Magazine's 2009 'Best Companies'.
Biotech Week - October 07, 2009 - AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve.
Biotech Week - September 30, 2009 - AstraZeneca could face bid after [pounds sterling]4bn Solvay takeover.(Business)
The Daily Mail (London, England) - September 29, 2009 - AstraZeneca's Seroquel XR, Seroquel aproved in EU.
Nordic Business Report - September 29, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning